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Abstract
In the environment, vanadium-dependent haloperoxidases (VHPO) are likely to play a key 
role in the production of biogenic organo-halogens. These enzymes contain vanadate as a 
prosthetic group, and catalyze, in the presence of hydrogen peroxide, the oxidation of halide 
ions (Cl-, Br- or I-). They are classified according to the most electronegative halide that they 
can oxidize. Since the first discovery of a vanadium bromoperoxidase in the brown alga 
Ascophyllum nodosum thirty years ago, structural and mechanistic studies have been mainly 
conducted on two types of VHPO, chloro- and bromoperoxidases, and more recently on a 
vanadium-dependent iodoperoxidase. In this review, we highlight the main progress obtained 
on the structure-function relation of these proteins, based on biochemistry, crystallography 
and X-ray absorption spectroscopy (XAS). The comparison of 3D protein structures of the 
different VHPO helped identify the residues that govern the molecular mechanisms of 
catalysis and specificity of VHPO. Vanadium K-edge XAS gave further important insight to 
understand the fine changes around the vanadium cofactor during the catalytic cycle. The 
combination of different structural approaches, at different scales of resolution, shed new light 
on biological vanadium coordination in the active site, and its importance for the catalytic 
cycle and halide specificity of vanadium haloperoxidases.
Keywords (max 6)
Vanadium-dependent haloperoxidase, vanadium coordination, crystallographic structure, 
structural evolution, oligomeric state, X-ray absorption spectroscopy on biological vanadium
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1. Introduction
In Nature, many organic compounds incorporate halogen atoms, which is often an 
essential step for the biological properties of halogenated antibiotics, drugs or signaling 
molecules [1]. Halogenated natural products are most commonly chlorinated or brominated, 
while iodinated and fluorinated compounds are rare, and all structural classes of chemicals are 
represented, from simple phenolic and aliphatic compounds, to complex alkaloids,
polyketides and oligopeptides [2, 3]. A large majority of the biogenic halogenated compounds 
have been isolated in marine organisms, especially marine macroalgae, which seem to be
important actors of iodine and bromine transfers in the coastal marine environment [4-6]. 
Among halogenating enzymes, haloperoxidases utilize hydrogen peroxide for electrophilic 
halogenation, via the oxidation of halides according to the following reaction: H2O2 + X
- + H+
→ H2O + HOX, wherein X- represents a halide ion and may be Cl-, Br- or I-. Haloperoxidases 
have been classified in two groups, according to the nature of their cofactor, vanadium or 
heme (iron-containing porphyrin) [1, 7-10]. Metal-free haloperoxidases have also been 
described in some bacteria [11]. Since the discovery of the first heme haloperoxidase, in the 
1960s, from the terrestrial fungus Caldariomyces fumago [12] a number of other heme 
haloperoxidases have been characterized [1, 9]. In this review, we focus on the second 
important group of haloperoxidases, the vanadium-dependent haloperoxidases (VHPO). In 
marine algae, these enzymes could be involved in anti-oxidant protection and in chemical 
defense and are likely to have a key role in the biochemical part of the iodine and bromine 
cycling in marine environment [13, 14]. Starting with their discovery thirty years ago [15], 
this review highlights the main progress that has been obtained on the biochemistry and on the 
global and fine structural characteristics of VHPO, based on molecular cloning, 
crystallography and X-ray absorption spectroscopy (XAS). They are classified according to 
the most electronegative halide that they can oxidize, i.e. chloroperoxidases (VCPO) can 
catalyze the oxidation of chloride as well as of bromide and iodide, and bromoperoxidases 
(VBPO) react with bromide and iodide, whereas iodoperoxidases (VIPO) are specific for 
iodide. Until recently, only chloro- and bromoperoxidases from eukaryotic species have been 
studied, showing a fragmental view of this large enzyme family. Novel types of VHPO
discovered in marine bacteria give now some clues to explore new biosynthetic pathways of 
natural halogenated compounds through in vitro heterologous expression, but also to further 
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study the structure-function relationships in catalytic and specificity mechanisms, and to shed 
light on VHPO family evolution.
2. Biochemical and molecular characterization of vanadium haloperoxidases
2.1. On the discovery of vanadium-dependent haloperoxidases in the brown alga 
Ascophylum nodosum
Interest in peroxidases from brown alga arose in the 1970s, through studies related to 
the identification of antibiotics from algae reporting that phloroglucinol [16], and then 
oligomers [17] and polymers of phloroglucinol units [18] were detected in brown algae. These 
compounds were further characterized as phlorotannins as reviewed in [19]. It was rapidly 
hypothesized, that peroxidases may be involved in the formation of these phenolic 
compounds, unique to brown algae. Despite extraction difficulties, due to the complex 
materials (anionic mucilages containing alginate and fucans), peroxidase-activity was 
detected in some crude-extract of brown algae, but the enzyme activity was partially lost 
during the purification process [20]. Intense work finally led to the isolation of the first 
vanadium-dependent haloperoxidase from knotted wrack, the brown alga Ascophyllum 
nodosum (Fucaceae, Fucales, Phaeophyta), called AnI in 1984 [15], showing that this enzyme 
preferentially oxidized iodide and also bromide and thiocyanide in the presence of vanadium 
(V), but not chloride (reviewed in [21]). The addition of iron and other metal ions had no 
effect on the activity of the apoenzyme. This algal peroxidase thus was not a hemoprotein,
like other iodoperoxidases from plants such as the well-known horseradish peroxidases [22]. 
Anecdotal, in the 1970s, vanadium was not considered to be an essential element in biology or 
in medicine, and until 1984, no scientific study has reported that vanadium could be a natural 
component of any enzyme. Consequently the paper on the vanadium-dependence of this new 
algal haloperoxidase [15] was not accepted in the first instance. However, since vanadium 
accumulation has been reported in ascidians in 1911 by Henze [23] experiments to test the 
effect of vanadium compounds were proposed by Vilter and coworkers. Indeed H. Vilter had 
observed an effect when solutions were aliquoted using a Hamilton syringe that brought the 
solutions in contact with vanadium-containing steel. Inspired by these effects, significant 
increase in haloperoxidase activity was observed in subsequent experiments using vanadate-
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containing buffers. At that time, the detection of a vanadium-containing nitrogenase was also 
reported [24, 25]. In 1986, the vanadate cofactor was finally confirmed for the vanadium-
dependent haloperoxidase from A. nodosum [26] and for the alternative nitrogenase in 
Azotobacter chroococcum [27]. In parallel, several reports indicated that vanadium was 
indeed an essential trace element for animals [28], Chlorella [29-32], Enteromorpha and 
Fucus [33]. Since its discovery, AnI was used as a laboratory model enzyme for the 
understanding of VHPO properties. Numerous further studies were carried out to characterize 
the V coordination inside the active site of AnI (later called An-VBPOI in this review), based 
on electron paramagnetic resonance [26, 34, 35], on 51V NMR [36-38], X-ray crystallography 
[39, 40] and on XAS ([41-43] see below).
2.2. Biochemical characterization of vanadium haloperoxidases
Vanadium-dependent haloperoxidases (EC 1.11.1.10) catalyze the two-electron 
oxidation of halides (X- : I-, Br- or Cl-) in the presence of hydrogen peroxide (H2O2) by a bi-bi 
ping-pong mechanism. During the catalytic cycle, the vanadate cofactor, at the resting (V) 
state, first coordinates one molecule of H2O2 to form a stable peroxovanadate intermediate, 
which can then react with halide. After halide oxidation, the electron oxidized halogen 
intermediate “X+”, which is a mixture of different halogen species such as OX-, X3
- or X2, 
may rapidly halogenate organic substrates in a non-enzymatic reaction (Scheme 1). In the 
absence of organic substrate, a second equivalent of H2O2 is oxidized to form a single oxygen 
and X- [for reviews 1, 7, 8, 10, 44].
2.2.1. Haloperoxidase in vitro assays
For kinetic studies, vanadium and heme haloperoxidases differ from other enzymes by 
the production of this very reactive and undetectable intermediate “X+”. Standard assays for 
the determination of VHPO activity are therefore based on the reactivity of this mixture with 
commercial chemicals. Phenol red and o-dianisidine were first reported as chemical probes
for the detection of VHPO-catalyzed halogenation, but are restricted to qualitative studies [45-
47]. The monochlorodimedone (MCD) halogenation provides a simple assay to determine 
steady-state kinetic parameters of VCPO and VBPO at acidic pH by monitoring the loss of 
absorbance of MCD at 290 nm [48-50]. The triodide (I3
-) assay (reviewed in [21]) was used to 
identify the first VIPO, i.e. specific for iodide oxidation, in brown algae of the Laminariaceae 
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family [51-54]. However, this assay presents important limits due to the high chemical 
instability of I3
- in solution. For this reason, a colorimetric assay was later developed for the 
titration of both iodo- and bromoperoxidase activities based on the reactivity of 
thymolsulfonephthalein, also named thymol blue (TB) toward oxidized bromide and iodide 
species [55]. Using this assay, novel VIPO were recently characterized in the marine bacteria 
Zobellia galactanivorans [56].
2.2.2 Biochemical coordination of V in vanadium haloperoxidases 
Vanadate (VO4) is the prosthetic group of VHPO and its incorporation into the 
enzyme is necessary for the catalytic activity. Indeed the apoenzymes, produced through 
dialysis, feature a drastic decrease of activity, while the reconstitution of VHPO with aqueous 
sodium orthovanadate leads to progressive and full recovery of haloperoxidase activity [15, 
35, 57-60]. The ratio of vanadate per protein subunit was estimated around one VO4 per 
subunit, but was lower in VBPOII from A. nodosum [60]. The affinity of VHPO for vanadate 
depends on pH [15, 61, 62], and is much stronger than for oxyanions, such as phosphate or 
molybdate (HVO4
2- >> HPO4
2- > AsO4
3− > MoO4
2-) [34, 61]. However, the peroxidase activity 
decreases in phosphate-containing buffers [21].
Unlike the heme-containing enzymes, there is no change in the oxidation state of the 
VHPO metal center during the synthesis of the halogenating agent, making them insensitive 
to oxidative inactivation during turnover. VHPO enzymes are also extremely thermostable, 
resistant to high concentration of organic solvents such as methanol, ethanol, 1-propanol, 
acetone [45] and dioxane and still active in concentrated solutions of guanidine hydrochloride 
or SDS [61, 63].
2.2.3 Vanadium haloperoxidase – catalyzed halogenation
Because of their biochemical properties, VHPO have received increasing attention as 
biocatalysts for pharmaceutical and biotechnological applications [44, 64]. The halogenation 
mechanism of VHPO is still debated for unspecific diffusible species-mediated halogenation 
versus specific halogenation of substrate into the active site. The main bottleneck for 
deciphering the biochemical role of an enzyme is to find its natural organic substrate. The 
specific halogenation patterns in natural organohalogens suggest that VHPO catalysis is 
stereo- and regio-selective in vivo [64]. However, only few reports are available about the 
chemical characterizations of natural substrates, deduced from VHPO-based halogenation in 
vitro. Data are indeed restricted to either purified native VHPO, as those from A. nodosum
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[44, 60], or to recombinant active enzymes, which have been successfully over-expressed in 
E. coli [65-67], in yeast system [58, 59], or in other heterologous systems [68-70] (see Table 
1 for complete references).
VHPO activities have been detected in a very large number of marine macroalgal 
classes using MCD or I3
- assays [21], but the corresponding biochemical data are very limited 
in early studies because of the difficulties to purify such enzymes from algal matrices 
extremely rich in anionic polysaccharides and polyphenolic compounds. The problem was 
solved by developing two-phase extraction procedures, and brown algal peroxidases were 
obtained in gram-amounts [20]. Up to now, a number of VHPOs have been characterized at 
the biochemical and molecular levels from red and brown macroalgae, terrestrial fungi and 
marine bacteria (see Table 1 for complete references). In the brown alga A. nodosum, the two 
VBPO isoenzymes present at different locations in the alga [61, 71] feature distinct 
biochemical and structural properties [60], suggesting distinct biological roles in the algal 
physiology. In vitro halogenation experiments have shown that purified native VBPOI from 
A. nodosum catalyzes the bromination of pyrroles [72] or phenols [73], whereas the second 
VBPO is involved in the biosynthesis of methyl 4-bromopyrrole-2-carboxylate, a natural 
product isolated from the marine sponge [60]. Laminaria digitata also features two isoforms 
of VHPOs, but with distinct halide specificities. One is a VBPO [53], whereas the other 
isoform is specific for iodide oxidation [54]. No specific iodinated substrate has been yet 
identified in L. digitata, but this particular VHPO may be involved in the very efficient 
accumulation of iodide in external tissues of L. digitata [14, 74, 75]. Another VIPO was 
recently characterized at the structural level in the marine flavobacterium Z. galactanivorans, 
which belongs to the bacteroidetes and is associated with both red and brown seaweeds [56].
In red algae (Table 1), VBPO were isolated from Corallina officinalis and Corallina 
pilulifera [76-79], and more recently VBPO from Delisea pulchra [80] and from Gracilaria 
changii [81]. The VBPO-catalyzed asymmetric bromination and cyclization of certain 
terpenes, including nerolidol, lead to the biosynthesis of brominated cyclic sesquiterpenes. 
This was established in vitro by VBPO isolated or cloned from Laurencia, Plocamium and 
Corallina [82]. The VBPO from Delisea pulchra produces bromofuranones, which are 
involved in the disruption of quorum sensing of epiphytic bacterial biofilms [80]. Algal 
halogenated compounds are known to interfere with bacterial signaling systems. Similarly, 
VBPO from L. digitata can deactivate acylated homoserine lactones, which are the cell-to-cell 
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signaling molecules. Moreover halogenated compounds from this species control the biofilm 
formation and growth in Gram-negative bacteria [83, 84].
VCPO were first characterized in terrestrial fungi, the most studied being that of 
Curvularia inaequalis ([85], Table 1 for full references). The fungus C. inaequalis is able to 
chlorinate aromatic rings of lignin in wood during the degradation process and this action is 
likely to be due to the presence of VCPO enzymes [86]. The VHPO-based biofilm control has 
been also explored for medical purposes: VCPO from C. inaequalis has an antimicrobial 
action on Enterococcus faecalis biofilms [87]. 
VCPOs were also identified in marine actinobacteria [68, 88]. Another class of 
interesting compounds is that of halogenated antibiotics. Interestingly, bromoperoxidase 
activity was first detected in the chloramphenicol-producing actinomycetes [89]. In 
Streptomycete bacteria, a VCPO, encoded by the NapH1 gene, catalyzes a highly 
stereoselective chlorination cyclization reaction in napyradiomycin biosynthesis [68, 88]. 
More recently in vitro biosynthetic experiments established the roles of VCPO from the 
marine bacterium Streptomyces sp. strain CNH-189 in the final chlorination cyclization step 
of the merochlorin biosynthesis. The existence of a highly regiospecific and stereospecific 
reaction in this synthesis of chlorinated antibiotics suggests that in vivo the VHPO bind their 
natural substrates in a highly specific manner [69, 70].
2.3. Phylogenetic relationships of vanadium haloperoxidases
VHPO share a relatively low level of overall protein sequence identity. For instance, 
the fungal VHPO from C. inaequalis [85] and Alternaria didymospora [90] present a protein 
sequence identity of 68%, and the protein sequence identities between VHPO from brown and 
red algae are only in the range of 30 to 40%. At the protein level, only one hundred amino 
acid residues from the carboxyl terminal regions of the fungal enzymes can be aligned with 
VHPO from macroalgae, with ~25% of similarities. This alignment bears the two following 
short domains highly conserved in all VHPO proteins and related to vanadate binding (see 
below).
(1) PxYxSGHA
(2) LxxxxAxxRxxxGxHxxxD
A phylogenetic analysis based on the alignment of 26 biochemically- and/or 
structurally-characterized VHPO (Table 1) was carried out, including four sequences of 
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bacterial nonspecific acid phosphatases as outgroup [7, 56]. In this phylogenetic tree (Figure 
1) the VHPOs from red and brown algae group together with some VBPOs from 
Cyanobacteria, suggesting a common origin of all algal VHPOs. Inside the brown algal 
VHPO sub-group, two branches appear, one including the first VBPO of A. nodosum and the 
VIPO from L. digitata and the other bearing the second isoform of A. nodosum and the VBPO 
of L. digitata [56]. The red algal VBPOs form a strong monophyletic group with few 
cyanobacterial VHPO homologous proteins, one of which has recently been characterized as 
VBPO in a Synechococcus strain [91]. In the other part of the tree (Figure 1) the VIPO from 
Z. galactanivorans, the fungal VCPO, including that of C. inaequalis, and the first bacterial 
VCPOs characterized in Streptomyces species merge as different monophyletic groups. A 
recent larger phylogenetic analysis allowed the identification of numerous VHPO bacterial 
homologs in public protein databases, suggesting a larger spreading of VHPO in bacterial 
lineages and a significant bacterial contribution to VHPO-mediated processes [56]. Based on 
phylogenetic analyses VHPO could derive from a common marine bacterial ancestor, closely 
related to bacterial acid phosphatases, and their evolution may have been driven by successive 
lateral transfer events. Moreover the specificity for iodide oxidation results in a convergent 
evolution of the divergent phyla of bacteroidetes and brown algae [56].
3. Structure/function of vanadium haloperoxidases
3.1. 3D crystallographic structures and quaternary arrangement of vanadium 
haloperoxidases
In 1996, Messerschmidt and Wever published the first crystallographic structure of a 
vanadium dependant haloperoxidase, which was the chloroperoxidase isolated from the 
fungus Curvularia inaequalis [92]. The overall shape of the monomeric protein has the form 
of a cylinder of about 80 Å long and 50 Å in diameter (Figure 2A). The fold is compact with 
about 44% of the residues involved in alpha-helices. The helices form two main domains 
consisting of a helix-bundle each that are related by a pseudo-2-fold axis perpendicular to the 
axes of the helices. The two helix-bundles are often called bundle 1 and 2, in relation to their 
occurrence in the N- or C- terminal part of the enzyme, respectively. The site of fixation for 
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vanadate is located at the bottom of a 20 Å deep cavity, situated at the N-terminal ends of 
helices from bundle 2 (Figure 2A-B).
A few years after this first structural characterization of a fungal VHPO, structures of 
a VBPO of algal origin were published (see Table 1 for full references), revealing complex 
multimerization of these latter ones. Indeed, the first characterized VBPO from the brown 
alga A. nodosum is arranged in dimers, stabilized by two disulfide bridges covalently linking 
the two monomers (Figure 2C) [39]. These dimers are able to self-arrange in more complex 
structures, such as hexameric proteins, as shown by gel filtration chromatography results 
obtained for VBPO from L. digitata [53] and for the second VBPO from A. nodosum [60]. In 
contrast, the red algal VHPO dimers are not stabilized by covalent bonds but organized in a 
hexamer of dimers (Figure 2D) [93, 94]. This dodecamer is about 150 Å in diameter and 
forms a cavity in its center. This multimeric complex also presents a high degree of 2-3-point 
group symmetry that is cubic. Interestingly, so far in all characterized algal VHPOs, the N-
terminal helix-bundle is structurally replaced by the C-terminal helix-bundle of a second 
monomer in the homo-dimeric protein, with the two molecules arranged in a ‘head-to-tail’ 
orientation. Multimerization is a biological strategy to stabilize proteins [95]; consequently, in 
the case of red algal VHPOs, the high stability to organic solvent and high temperature might 
be a result of the strong interactions present in these highly symmetric multimers. In VBPO 
dimers, the surface of interaction represents 20 and 46% of the total exposed surface of a 
monomer for C. officinalis [93] and A. nodosum [39], respectively. In contrast, in the red algal 
VBPO dodecamer, only 12% of a monomer surface is exposed to the solvent [93, 96, 97].
More recently, 3D structures from bacterial VHPOs (Table 1), the VCPO from 
Streptomyces sp. (Liscombe et al., unpublished) and the VIPO from the marine 
flavobacterium Z. galactanivorans [56] have shed new light on plausible evolutionary 
relationships between algal multimeric forms and fungal and bacterial monomeric forms of 
VHPOs. Indeed, the two bacterial VHPOs are similar to the monomeric fungal VCPO, 
consisting of two helix-bundle domains within a single polypeptide chain in the VIPO from Z. 
galactanivorans (Figure 2B). Despite this fold-similarity, the Z. galactanivorans VIPO is a 
monomer in solution, while VCPO of Streptomyces sp. is dimeric. However, the dimerization 
mechanism in this latter case is very different to that found in algal VHPOs, and probably 
carries a different biological function. The Streptomyces sp. VCPO dimer-interface is located 
above the N-terminal helix-bundle, where two small (3 to 4 residues) beta-strands form an 
anti-parallel beta sheet. The longest beta-strand of each monomer interacts with the equivalent 
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one in the second monomer, in an anti-parallel manner, and together they create an interface 
much smaller than that observed in the complex multimeric algal VHPOs.
As explained above, the vanadium containing active site of VHPOs is located at the N-
terminal end of helices from bundle 2 in fungal and bacterial VHPOs (Figure 2A-B), , and 
two residues within the second ligand sphere of the VO4
3- are provided by the helix bundle 1. 
This vanadium binding site structure is perfectly conserved throughout all VHPOs (see 
below), despite the fact that the algal VHPO lack the helix bundle 1. Indeed the missing
helices are replaced by the second monomer in the dimeric forms of VHPOs. Nevertheless, all 
VHPOs have roughly the same number of residues, between 450 and 550 amino acids. 
Indeed, algal VHPOs display several additional insertions, forming helices and beta-strands 
that are not present in the fungal or bacterial VHPOs [56]. The comparison of all the known 
haloperoxidase structures shows that a fungal or bacterial VHPO monomer can be 
superimposed onto the dimer of an algal VHPO, with the N-terminal helix-bundle 1 of the 
single peptide chain in the monomeric forms being replaced by the ‘back-side’ of the C-
terminal helix-bundle belonging to the second chain of the homodimeric form (Figure 2C). 
This observation, combined with phylogenetic analyses, has allowed postulating a bacterial 
origin of the ancestral VHPO with a monomeric conformation [56]. In this scenario the loss of 
helix bundle 1 in algal VHPO, has probably been the key to dimerization: an incomplete gene 
transfer leading to the deletion of helix bundle 1 exposes a hydrophobic patch at the surface of 
the protein, necessitating the replacement of this part of the fold by a helix bundle from a 
second monomer, thus facilitating the dimerization. The dimerization leads to the interesting 
feature that the homodimeric algal VHPOs have two vanadate-containing active sites, 
whereas the fungal and bacterial monomeric forms only possess one active site per protein.
3.2. Similarities between vanadium haloperoxidases and acid phosphatases
In monomeric VHPOs the two domains of the same protein, the conserved C-terminal 
helix-bundle and variable N-terminal helix-bundle, can be superimposed on each other at the 
structural level (Figure 3A), despite the fact that no similarity can be detected between the 
two helix bundles at the level of primary sequence. Interestingly, the 3D structural fold of acid 
phosphatases, represented through the monomer structure of a non-specific acid phosphatase 
from Escherichia blattae [98] is constituted by a single helix-bundle motif. Indeed, when 
structurally superimposing the five-helix-bundle of an acid phosphatase onto monomeric 
VHPOs, stronger similarity can be observed with the conserved C-terminal helix-bundle 
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domain than when superimposing onto the variable N-terminal helix-bundle of VHPOs 
(illustrated by the superimposition onto the C-terminal helix-bundle of Zg-VIPO1 in Figure 
3B). This structural domain homology to acid phosphatases has been previously identified by 
the comparison to Ci-VCPO [98-100]. Together with phylogenetic analyses [56], these 3D 
fold-similarities suggest that acid phosphatases and VHPOs have a common ancestor with an 
ancestral fold consisting of a single helix-bundle-based core domain, and VHPOs have 
diverged from this ancestor fold by gene-duplication followed by gene-fusion. In this 
scenario, the presence of additional ligands provided by the second helix-bundle has led to the 
fixation of catalytic active vanadate rather than phosphate. However, we can not rule out that 
ancestral active VHPOs contain only a single helix bundle that have then diverged into two 
distinct forms, either by dimerization or by gene-duplication followed by gene-fusion. In any 
case, this evolutionary relationship between phosphatases and VHPOs has some functional 
consequences: since the phosphate and vanadate binding sites are sufficiently similar, it has 
been demonstrated that the apo-form of VCPO exhibits phosphatase activity [101], whereas 
the phosphatases are strongly inhibited by vanadate [102]. In several 3D structures, bound 
phosphate was located in VHPOs in a similar manner than the vanadate group, either in the 
native Ci-VCPO [92] or in the VBPO of Corallina species [93, 94, 103]. This oxyanion is 
only weakly linked to the Nε atom of the histidine residue, but a systematic comparison of 
phosphate- and vanadate-binding proteins in the protein data bank shows high structural 
similarities and similar binding [104].
3.3. VO4 coordination in the crystal structure of vanadium haloperoxidases
When studying the molecular bases of catalytic properties and halide specificity in 
VHPO, it is of interest to compare the 3D active site structures of the different types of 
VHPO, i.e. the fungal and bacterial VCPO, the algal VBPO, and the recently discovered 
VIPO from Z. galactanivorans [56]. The active site pockets of the different VHPOs display 
strong similarities, despite the different oligomeric forms of enzymes, and most of the 
residues tightly coordinating the catalytic vanadate are strictly conserved within C-terminal 
helix bundle (Figure 4), the active site pocket being also delimited by the neighboring N-
terminal helix bundle in fungal and bacterial VHPOs and by the C-terminal helix bundle from 
the second monomer in algal VHPOs (Figure 2).
The N group of a strictly conserved histidine (His416, His496, His494, His486, His553 
and His553 in Zg-VIPO1, Ci-VCPO, Ssp-VCPO, An-VBPOI, Co-VBPO and Cp-VBPO, 
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respectively, Figure 4A-F) is binding the vanadate, providing the fifth atom in the trigonal-
bipyramidal coordination sphere of vanadium (V). As mentioned above, the VO4 binding in 
VHPOs also corresponds to the assumed trigonal bipyramidal transition state of bound 
phosphate in the phosphatases [104]. All other ligand-atoms of the vanadium-ion are the four 
oxygens from the prosthetic group. These oxygen atoms are in turn hydrogen bonded by a 
lysine, a serine, a histidine and two arginine residues that are all conserved, with one 
exception, viz. the replacement of the histidine (His360 in Zg-VIPO1, Figure 4A) by a serine 
in the bacterial VCPO (Ser427, Figure 4C). 
For the VCPO from the fungus C. inaequalis the X-ray structures of both native and 
peroxide forms of the enzyme have been solved at 2.03 Å and 2.24 Å, respectively [105]. 
These two structures have revealed that the trigonal bipyramidal geometry of the vanadate in 
the native form is transformed in a distorted tetragonal pyramid after addition of hydrogen 
peroxide, suggesting the release of the apical oxygen ligand and the coordination of the two 
peroxide oxygens to the vanadium cofactor in the stable peroxide form of the enzyme ([105], 
see Scheme 1). During the catalytic cycle, at least the histidine and one arginine (His360 and 
Arg410 in Zg-VIPO1, Figure 4A) are essential residues for the coordination of the vanadate 
moiety and catalysis, since changing them into alanine or serine totally switched off 
haloperoxidase activity in Ci-VCPO [58, 106] and in Zg-VIPO1 [56]. In the VCPO from 
Streptomyces sp., the serine residue (Ser427) seems to play a similar role, as its mutation in a 
histidine residue abolished enzyme activity [68]. 
Another remarkable difference in the bacterial VCPO and in all algal VBPOs is the 
presence of an additional histidine, in the proximity of Lys341 (An-VBPOI numbering, 
Figure 4D) that is replaced by a phenylalanine in the fungal VCPO. Based on the first few 
available crystal structures [39, 92-94, 103], it was postulated that this single residue-
difference between vanadium-dependent chloro- and bromoperoxidases, i.e. a Phe397 in
VCPO (Figure 4B) replacing a histidine residue in VBPO, was responsible for the difference 
in halogen specificity [66]. Previously, the mutation of the arginine residue (Arg397) in the 
red algal VBPO from C. pilulifera (Figure 4F) has conferred significant chloroperoxidase 
activity to mutant enzymes R397W and R397F [94, 107]. This residue is replaced by a 
tryptophan residue in the fungal VCPO. However, the more recent crystal structure of VIPO, 
having identical residues in the first coordination sphere of the catalytic vanadate as in VCPO 
[56] including this phenylalanine, showed that the structural factors governing the oxidation 
potential of halides in this enzyme family is much more complex. In this latter study, site-
directed mutagenesis of residues located in a second sphere around the active site highlighted 
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that some of these could equally well influence the halide-oxidation potential of this enzyme, 
and even the specificity of the enzyme. Indeed a slight bromoperoxidase activity was obtained 
in two enzyme mutants, one mutated inside the active site (Ser358, Figure 4A) and the other 
mutated on a tyrosine residue located outside the active site. The current hypothesis [7, 8, 55]
explains the change of catalytic properties and halide specificity by modifications of H-bond 
coordination and redox potential of the VO4 moiety, rather than selective halide binding. 
Recent data suggest that this redox potential is finely tuned locally, but also by remote amino 
acid residues, belonging to the second and third sphere of VO4 coordination [56].
4. Biological Vanadium K-edge X-ray absorption spectroscopy 
4.1. Introduction to BioXAS and other biological Vanadium XAS results.
4.1.1 X-ray absorption spectroscopy
X-ray absorption spectroscopy (XAS) is applied to study the coordination geometry of 
transition metals in enzymes, as well as changes of geometry during catalysis [108, 109]. The 
method can also be applied to non-invasively study halogens in whole organisms [14], parts 
thereof [110, 111], or isolated enzymes [112]. The X-ray absorption spectra of dilute systems 
(mM in metal) like biological samples are usually measured in fluorescence mode; for 
vanadium this is relatively difficult compared to other 1st-row transition metals, because there 
is less fluorescence and the K-edge is at low energy, a range where air absorbs significantly. 
Some examples of vanadium K-edge spectra are shown in Figure 5.
With monochromatic synchrotron radiation, it is possible to scan the X-ray energy 
around the so-called K edge of an element, for example vanadium (V). At the absorption 
edge, the X-ray energy corresponds to what is needed to liberate a 1s electron of V into the 
continuum. The edge energy shifts to a higher value if the V is in a higher oxidation state. 
There is usually some fine structure present in this ‘X-ray Absorption Near Edge spectrum’ 
(XANES) which can also be represented as the first derivative in order to highlight subtle 
features (Figure 5A-B). The fine structure is due to the electron being excited to unoccupied 
higher orbitals with energies just below that of the continuum; the intensities of such 
transitions depend on their being allowed or forbidden, which in turn depends on the metal 
ion’s coordination geometry. Above the edge, additional features, the so-called ‘Extended X-
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ray Absorption Fine Structure’ (EXAFS, Figure 5C) are observed, which are due to X-ray-
induced electron diffraction phenomena and can be interpreted in terms of distance, number, 
and type of the surrounding ligands. The EXAFS is usually displayed with the wave vector k
(Å-1) as energy axis, and in k3-weighting to compensate for the decay in amplitude at higher k. 
The EXAFS amplitude depends on the coordination number but this can only be determined 
with limited accuracy (± 1) because of its correlation with the disorder phenomena, described 
in the so-called Debye-Waller factor, that are responsible for the aforementioned decay in the 
amplitude. Fourier transformation (with phase correction) of the EXAFS (FT, F gure 5D) 
yields a radial distribution function in which the positions of the maxima represent the 
distances of shells of ligand atoms to the absorber atom, which can be determined fairly 
accurately (typically ± 0.02 Å). Atom types differ in backscattering amplitudes and in the 
phase relationship between EXAFS and Fourier transforms; atoms of the same row in the 
Periodic Table are so similar that they cannot easily be distinguished (Z determined to an 
accuracy of ± 1). Ligands like the imidazole moiety of the amino acid histidine give a
characteristic pattern of shells for which the multiple scattering phenomenon, i.e. the 
scattering of the electron wave by various ring atoms before it returns to the V absorber, has 
to be taken into account in the simulation. The interpretation of EXAFS is performed by 
means of simulation on the basis of parameters of structural models which are iteratively 
refined to give the optimum agreement between theory and experiment as expressed in a fit 
index.
4.1.2. Biological vanadium accumulation
Because of the relatively high concentration requirements it is not surprising that the 
first example of a study of vanadium in a biological context was on organisms that actively 
accumulate vanadium from seawater, in the form of  vanadate (V(5+)O4
3-), viz. of the 
aforementioned as idians [23], a class belonging to the phylum of tunicates [113]. The 
XANES of these organisms, when compared to that of suitable model compounds, showed 
that the vanadium was predominantly in the V(3+) state in an octahedral environment, while 
the EXAFS revealed the nearest neighbours to be oxygens. In subsequent studies, the V 
XANES features were used to quantify the amounts of V(3+) ions associated with the 
biological catecholate-based chelator tunichrome, and water and sulphate, as well as mixtures 
of the latter in various species [114-118], and a detailed mechanism for the reduction of 
vanadate to V(3+) was proposed [119]. In this particular context, the role of sulphur in the 
vanadium metabolism was also investigated with sulphur K edge XANES [120-122]. Micro-
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distribution of V was established in living ascidian blood cells by X-ray scanning microscope 
in fluorescence mode and local XANES spectra revealed V(3+) and V(4+) in vivo [123]. With 
X-ray tomography in combination with X-ray fluorescence, three-dimensional maps of the 
element distribution in objects and biological specimens such as the diatom Cyclotella can be 
obtained [124]. With scanning X-ray microscopy, it is possible to record short ranges -
XANES rather than EXAFS - of X-ray spectra at the edge of an element, and combine them 
with the image, to map the distribution of that element's oxidation state. This is an interesting 
approach for vanadium because of the sensitivity of its XANES to oxidation state and ligand 
geometry. In applications [125-126] of this technique in relation to the aforementioned 
biological vanadium accumulation, a scanning X-ray microscopy study of cryo-fixed 
specimens of one type of blood cell - the so-called signet cell - from Ascidia sydneiensis 
samea , it was shown that the reduction of V(5+) from seawater proceeds in 2 steps, viz. to 
V(4+) in the signet ring cells, and to V(3+) in the vacuole. One other occurrence of vanadium 
in a biological context, besides that of V in haloperoxidases, is that in aforementioned
vanadium-dependent nitrogenases [28, 127]. The XANES and EXAFS at the V K-edge of the 
first V-containing nitrogenase from A. chroococcum resembled very much that of a VFe3S4
cubane cluster [128].
4.2. Vanadium and other edge EXAFS and XANES of vanadium haloperoxidases
4.2.1. Early vanadium haloperoxidase XANES results 
Studies on the vanadium-containing haloperoxidases started with XANES of the 
brown alga A. nodosum bromoperoxidase [41]. The prominent pre-edge peak at 5469 eV 
(Figure 5A) is ascribed to a 1s-3d transition which is dipole-forbidden and absent in 
octahedral VO [129] but very strong in tetrahedral vanadate (Figure 5A). For the native 
bromoperoxidase of A. nodosum, the feature is somewhat weaker than for vanadate (Figure 
5A, [42]) which is consistent with the trigonal bipyramidal coordination symmetry established 
in the crystallographic study [39]. A similar change was observed in the XANES of vanadate 
upon binding to the chloroplast H+-ATPase CF1 together with Mg2+ and ADP; this creates an 
enzyme-bound transition-state analogue for ATP-hydrolysis in which the V has trigonal-
bipyramidal coordination geometry [130].
The haloperoxidase XANES is not affected by addition of the substrate Br- (90 molar 
equivalents), but upon reduction the edge shifts to lower energy and the pre-edge feature is 
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reduced in intensity [42]. Addition of 4 molar equivalents of H2O2 had no effect [42] but a 
significant shift of the edge to lower energy and a subtle increase in the pre-edge feature were 
observed with 15 molar equivalents [43]. These changes point respectively to an increase in 
average V-ligand distance and to a change in symmetry, but not to a change in oxidation state 
for V. Accordingly, a mechanism was proposed for VHPO-based bromination (Scheme 1) 
without valence change for V nor coordination of Br- to V, in which coordination to V(5+) 
activates H2O2 for attack by bromide, forming the hypobromite which is the halogenating 
agent.
4.2.2. Vanadium haloperoxidase EXAFS
The first haloperoxidase EXAFS was obtained for the native and reduced forms of A. 
nodosum VBPOI in a k range of 3-10 Å-1 [42] at a time when no crystallographic information 
was yet available. For the reduced enzyme, one short (1.63 Å) and 3 medium (1.91 Å) V-O 
distances were identified, along with two V-N distances of 2.11 Å, which were inferred to 
belong to imidazole moieties of histidine residues on the basis of advanced EPR (electron spin 
echo) studies [43], and simulated as such. The results for the native enzyme were similar, but 
most distances (1.61, 1.72, and 2.11 Å) were shorter, and the more remote atoms were not 
explicitly assigned to imidazoles but as N or O. In a later study [131], the distance 
information was used in a Bond Valence Sum Analysis (BVSA) [132], using known 
correlations between the valence, ligand distances, and ligand geometry of ions, to correct the 
coordination number initially found [42] from 6 to 5. If one considers one of the imidazole or 
N/O ligands from the initial interpretation to be redundant in the 5-coordinate geometry, this 
outcome is consistent with the crystallographic results, first for the VCPO from the fungus C. 
inaequalis [92], later for the A. nodosum VBPO [39], that vanadium in haloperoxidases is 
present as vanadate, bound to the enzyme by coordination to a single imidazole residue.
Although the imidazole ligand was recognized in the EXAFS of reduced enzyme on 
the basis of the EPR evidence [133], it was almost overlooked in the native enzyme [42].The 
aforementioned current structural model for the nitrogenase cofactor FeVco also features 
imidazole coordination, although this is not detectable in the EXAFS. The crystal structure of 
the [vanadyl(vinylimidazole)4Cl]Cl complex revealed V-N distances in the range 2.05-2.19 Å, 
and the imidazoles gave an unambiguous contribution to the EXAFS in the Fourier transform 
(radial distribution function) in the range 2-4 Å, with an average distance of 2.11 Å [134], in 
line with the V-N distance found in the A. nodosum VBPOI EXAFS [42]. It is clear from the 
features in the EXAFS in the range 2-4 Å-1 (Figure 5C) that there are remote shells in 
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addition to the main shell of oxygen (and nitrogen) ligand donors, atoms that also contribute 
to the EXAFS, but the corresponding features in the Fourier transform at 3-4 Å are relatively 
small (comparable to the intensity for vanadate in that region) if it is taken over a relatively 
long data range (Figure 5D). Alternative interpretations have been put forward for the remote 
haloperoxidase shells, such as a shell of protein heteroatoms that are H-bonded to the 
vanadate [135], and, by analogy to the archaeal tungstate binding proteins [136], through-
absorber multiple scattering involving the axial ligand donor atoms in the trigonal bipyramid, 
which would appear in the Fourier transform at the sum of the V-N(imidazole) and V-
O(axial) distances [137].
It was concluded from V EXAFS taken over a relatively short range (up to k = 7 Å-1) 
of the A. nodosum VBPOI in the presence of excess (3 molar equivalents) bromide that there 
is no direct V-Br interaction (expected distance 2.45 Å) [138, 139]. This was corroborated by 
the absence of such a contribution in the complementary Br EXAFS [140], which instead 
indicated the presence of Br covalently bound to a low-Z atom, then interpreted as due to a 
putatively reactive Br-O(Ser) intermediate. It was later found [112] that the enzyme actually 
contains endogenous bromine in the form of bis-brominated (3,5-dibromo)-tyrosine residues, 
presumably due to exposure to both Br- and H2O2 before or during isolation. Br EXAFS also 
revealed the presence of bromine incorporated in other amino acids, possibly tryptophan, in 
the VHPO of L. digitata [110].
As mentioned above, the crystal structures of the native [92] and peroxo [105] forms 
of the C. inaequalis VCPO indicated that two vanadate oxygens are displaced by the peroxide 
which is bound in a side-on fashion, and that the geometry changes from a trigonal bipyramid 
with the imidazole-N in one of the apical positions to a square pyramid with an apical oxygen 
(see Scheme 1 for a schematic representation of the structures, in which the ellipsoids indicate 
the equatorial planes). While the XANES of A. nodosum VBPOI showed a significant shift to 
lower energy with a large excess of H2O2 (see above) [43], indicating a longer average V-
ligand distance, the corresponding spectra for C. inaequalis VCPO with 4 molar equivalents 
of H2O2 were rather similar. The EXAFS of both enzyme forms was also measured, 
compared, and analyzed [141] in an approach in which the geometry of the imidazole was 
constrained [142], i.e. the atom-atom distances within the ring were kept in an idealized 
geometry, so that the whole imidazole was treated in the refinement of the simulations as a 
unit. The EXAFS distances agree within 0.1 Å to the crystallographic ones for the native 
enzyme, but in the peroxo form the crystallography seems to overestimate the V-N and two of 
the V-O distances by 0.15-0.25 Å. The comparison is complicated by the pH difference, 8.3 
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vs. 6.0 for diffraction and spectroscopy, respectively. While the crystal structures indicate a 
significant increase (up to 0.25 Å) in the V-ligand distances for the peroxo form, the EXAFS 
shows a small (up to 0.10 Å) decrease, if a change at all, which is in line with the C. 
inaequalis VCPO XANES results [141].
4.2.3. Outlook: merging XANES and EXAFS
As mentioned in the introduction, the XANES region of the X-ray absorption 
spectrum is usually treated as spectroscopy (interpretation in terms of transitions) and the 
EXAFS as (X-ray induced electron) diffraction. The EXAFS is simulated with 1-dimensional 
structural models (radial distribution function independent of the arrangement of the atoms in 
space) or sometimes 2-dimensional (multiple scattering within an imidazole ring) or 3-
dimensional models (through-absorber multiple scattering involving linear arrangements of 
absorber and 2 ligand atoms). It has been recognized for some time that it should be possible 
to simulate the XANES on the basis of the same structural models, but defined in 3 
dimensions, that account for the EXAFS; there is, however, as yet no convenient approach for 
the simulation of both regions of the spectra. The examples given above [42, 141] show that it 
is possible to simulate EXAFS data on the basis of the so-called ‘muffin-tin potential’ 
calculations, in which the atoms involved are potential wells separated by an area defined by a 
common interstitial potential. There is however a growing insight [142, 143] that such an 
approach is too crude to reproduce important features in the XANES, and that the more 
complex full-potential finite difference method [144] has to be applied to this region. The 
challenge now is to interpret both ranges of the spectrum with the same underlying theoretical 
model. One could go back and forth with one or more structural models between simulations 
of the XANES and EXAFS regions of the spectra, adjusting distance information in the 
EXAFS and 3-dimensional information in the XANES, until a consistent structural model has 
been reached. In view of the still increasing power of computational approaches such as the 
ADF Density Functional Theory package [145], it is also tempting to generate computational 
structures which can be validated/adjusted in both the EXAFS and XANES part of the X-ray 
absorption spectrum.
5. Conclusions and future prospects
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During the last thirty years, extensive research on different vanadium-dependent 
haloperoxidases was undertaken in order to characterize halogenation through VHPOs. Based 
on information coming from crystal structures, model compounds of the cofactor possessing 
catalytic center have been analyzed and modeled in order to understand the vanadium 
coordination occurring in proteins [146], although these models only account for the first 
coordination sphere observed in proteins. Extensive modeling and chemical analyses have 
also helped advance on the understanding of the mechanistic reactivity of this metal-organic 
active center, by predicting the most stable functional model, K[VO(O2)(heida)], to be an 
effective biomimetic catalyst for VHPOs, also providing an explanation for the differences in 
chloro- and bromo-peroxidases [147]. Much progress has also been obtained by classical 
biochemical studies, X-ray crystallography and spectroscopic analyses of the global and fine 
local structures of the native and peroxo-intermediate forms of the enzymes. The resolution of 
a protein crystal-structure of a VHPO specific for iodide oxidation [56] has recently allowed 
further exploring the molecular origin of halide selectivity, which still remains an intriguing 
question. Indeed the halide specificity in VHPO is related to many interacting factors, such as 
the amino acid composition of the active site and the fine electronic environment of the 
vanadate pocket. This latter study also showed that the 2nd coordination sphere of the peroxo 
intermediate appears to play an equally important role. In order to decipher the complete 
catalytic mechanisms of VHPOs and their contrasting reactivity towards different halides, it is 
important to pursue and enhance the combination of approaches, undertaking protein 
crystallographic studies in parallel to fine local structure analyses by XAS and EXAFS, on the 
different VHPO available and specific site-directed mutants that show modified biochemical 
kinetics. For instance, the fine tuning of the VO4 moiety during the catalytic cycle should be 
explored through the measurement and interpretation of the EXAFS and XANES of 
haloperoxidases at various edges in parallel (V, I, Br). These local structural studies not only 
provide a good starting point for computational studies on the protonation state of vanadate or 
on the catalytic intermediates [146, 148-151], but also provide the possibility to test structural 
hypotheses through analyses of point-mutants. VHPOs are indeed interesting models of 
research in chemistry to mimic the activity of vanadate centers, using oxidovanadium (IV) 
and dioxidovanadium (V) stabilized by organic molecules [45, 152]. However, recent studies 
[56] have shown that the influence of the protein stabilization of the active center goes beyond 
the first coordination sphere. At the long term, the biochemical and structural 
characterizations of known and supplementary VHPOs will be necessary, in particular at very 
high resolution (beyond 1 Å) and possibly using neutron-diffraction to precisely locate proton 
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positions, to infer global evolution of VHPO enzymatic mechanisms among bacterial and 
eukaryotic lineages.
Another black box remains the biological roles of these enzymes in living organisms. The 
very large panel of halogenated compounds produced by marine organisms, especially by red 
and brown algae, is likely to have important biological or ecological functions. Moreover the 
presence of a tremendous number of VHPO-homologs in all bacterial lineages suggest the 
involvement of VHPO-based halogenation in numerous bacterial biosynthetic pathways. In 
this biological context, an important bottleneck is the development of functional approaches 
for deciphering the biochemical functions of VHPO, for finding their specific substrates and 
for identifying the natural halogenated products, they are producing in vivo. The set-up of 
heterologous expression and in vitro reconstituted systems are challenging, especially for 
marine bacteria, but the recent results obtained on Streptomyces sp. [69, 70] have opened 
interesting perspectives in this research area. In future developments, these advances will 
certainly give rise to potential biotechnological applications either for generating halogenated 
biologically active analogues or for improving biological properties of metabolites by 
enzymatic halogenation.
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Table 1. Biochemical, molecular and structural characterization of vanadium-dependent 
haloperoxidases.
Species Activity GenBank 
Accession #
PDB 
Accession #
Mutants References
Ascophyllum 
nodosum
VBPOI 
VBPOII
P81701a
CCD42013
1QI9b
-
-
-
[15], [39]
[60]
VBPO CAD37191 - - [53]
B
ro
w
n 
A
lg
ae
Laminaria digitata
VIPO CAF04025 - - [54]
Corallina officinalis VBPO AF218810AAM46061
1QHBb
-
-
H480A
[93]
[65, 153]
Corallina pilulifera VBPOIVBPOII
1UP8_Aa
BAA31261
BAA31262
1UP8
-
R397X
-
[67, 94, 103, 107]
Gracilaria changii VBPO AGE00855 - R379F/H [81]
R
ed
 A
lg
ae
Delisea pulchra VBPO DpDV-BrPODpEV-BrPO - R553H [80]
Curvularia inaequalis VCPO CAA59686
1VNCb, 1IDQ, 
1IDU, 1VNE-I, 
1VNS, 3BB0
D292A, K353A, R360A, 
F397H, S402A, H404A, 
R490A, H496A, 
P395D/L241V/T343A
[58, 66, 85, 92, 
101, 105, 106,  
154]
F
un
gi
Alternaria 
didymospora VCPO CAA72622 - - [80]
Zobellia 
galactanivorans
VIPO1
VIPO2
YP_004735706
YP_004736527
4CIT
Y263A/S/F, C320S, 
W321A, D322K/Y, 
F353H, S358A, H360A, 
R410A
[56]
Synechococcus sp.
WH 8020 VBPO ADO20318 - - [91]
Streptomyces sp. 
CNQ-525
VCPO ABS50486 3W36 H420F, S427H
[68]B
ac
te
ri
a
Streptomyces sp. 
CNH-189
VCPO
AGH68925
AGH68909
- - [69, 70, 88]
VBPO: vanadium-dependent bromoperoxidase; VIPO: vanadium-dependent iodoperoxidase; VCPO: vanadium-dependent 
chloroperoxidase; X: all amino acids except R; a obtained by protein sequencing; b resolution of the crystal structure from 
the purified native protein
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Figure legends
Scheme 1. Proposed mechanism for vanadium-dependent haloperoxidase, with X- = 
halide. Left: ping-pong mechanism for the formation of the reactive intermediate OX- or ‘X+’. 
Ellipsoids indicate the equatorial planes of the trigonal bipyramidal and square planar 
coordination geometries of the native (top) and peroxo (bottom) enzyme forms, respectively. 
H2O2 atoms are tracked in red bold in the peroxo enzyme form (notice that one of the O in the 
vanadate of the native enzyme also originates from H2O2). Right: Overall reactions of the 
VHPO/H2O2 system. X: Br, Cl, I. R-H: organic compound. R-X: organohalogens.
Figure 1. Phylogeny of VHPO proteins.
A protein maximum likelihood (PML) tree was constructed using the multiple alignment of 
26 eukaryote and bacterial VHPOs characterized at the molecular and/or biochemical levels 
and of four Bacterial Acid Phosphatases as an outgroup. 173 informative residues were used 
for PML analyses and bootstrap values (500 replicates) are provided for main nodes. The 
NCBI accession numbers of proteins are indicated, except for VBPO from Plocanium 
cartilagineum (Pcar) and from Delisea pulchra (Dpul) (see [80]). The scale bar represents a 
difference of 0.1 substitution per site. When characterized at the biochemical level, the VHPO 
specificity towards halides is mention d and refers to the legend code, i.e. iodo- (VIPO), 
bromo- (VBPO) or chloroperoxidase (VCPO) activity. The available 3D structures of VHPO 
are indicated by a star. Examples of halogenated products are -, - and -snyderol and (+)-
3-bromo-8-epicaparrapi oxide [80], bromofuranone [80], napyradiomycin [68], merochlorin 
[69, 70], bromopyrroles [72] and bromophenols [73].
Figure 2. Three dimensional structures of VHPO. A. The monomeric VCPO from C. 
inaequalis (PDB Accession #, 1VNI). B. The monomeric VIPO1 from Z. galactanivorans
(PDB 4CIT). C. The homo-dimeric VBPOI from A. nodosum (PDB 1QI9). D. The 
dodecameric VBPO from Corallina officinalis (PDB 1QHB) and C. pilulifera (PDB 1UP8).
In the monomeric VHPOs (A and B), the N- and C- terminal parts of the protein containing 
the two helix-bundle domains are colored in blue and red, respectively. For the algal VHPOs, 
the red and blue colors are used to distinguish either the two identical monomers (B) or the 
different homodimers (D). The VO4 binding sites are indicated by an arrow.
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Figure 3. 3D structure comparaison of VIPO1 from Z. galactanivorans (PDB Accession 
#, 4CIT) and of non-specific acid phosphatase from Escherichia blattae (PBD 1D2T). A. 
Superimposition of the N-terminal helix bundle (in green) of Zg-VIPO1 onto its C-terminal 
helix bundle (in blue). B. Superimposition of the monomeric structure of Eb-NSAP (in pink) 
with a monomer of Zg-VIPO1 (in blue and green). The C-terminal helix-bundle that is 
conserved with other VHPO is represented in blue and the N-terminal helix bundle is colored 
in green. The VO4 or PO4 binding site is indicated by an arrow.
Figure 4. Comparison of vanadate-binding site structures of VHPO. A. VIPO1 from Z. 
galactanivorans (Zg-VIPO1, PDB Accession #, 4CIT). B. VCPO from Curvularia inaequalis
(Ci-VCPO, PDB 1IDQ). C. VCPO from Streptomyces sp. CNQ525 (Ssp-VCPO, PDB 3W36). 
D. VBPOI from A. nodosum (An-VBPOI, PDB 1QI9). E: VBPO from Corallina officinalis
(Co-VBPO, PDB 1QHB). F. VBPO from Corallina pilulifera (Cp-VBPO, PDB 1UP8). The 
view of the active site is looking inside, towards the axial histidine ligand at the bottom of the 
20 Å deep cavity, and amino acid residues are numbered according to the protein sequence.
Vanadate and phosphate are represented in the center of the picture. The H-bonds between 
VO4 or PO4 group and the surrounding amino acids are shown as dashed blue lines.
Figure 5. Example of vanadium K-edge X-ray absorption spectra. Comparison of (dashed 
red) Na3VO4 in Tris buffer pH 8.0 and (solid black) native VBPOI from Ascophyllum 
nodosum. X-ray absorption near edge spectra (XANES, top left, A) and 1st derivative (bottom 
left, B); extracted Extended X-ray Absorption Fine Structure (EXAFS, top right, C) and 
phase-corrected modulus of the Fourier transform of the EXAFS (bottom right, D). Spectra 
taken with Dr. W. Meyer-Klaucke at the EMBL Outstation at DESY, Hamburg, Germany.
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Highlights  
 
- 3D and XAS data are complementary to study Vanadium coordination and VHPO 
catalysis. 
- VHPO features a large evolutionary and structural diversity from bacteria to algae. 
- Bacterial VHPO revealed new biosynthesis pathways and enzymatic specificity. 
 
 
Graphical abstract 
The 3D-printed protein structure (*) and vanadium X-ray absorption near edge spectra obtained 
from the first vanadium haloperoxidase discovered 30 years ago. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(*) http://vilter.de/vanadium-dependent-haloperoxidase-from-ascophyllum-nodosum-
touchable-3d-models-from-x-ray-crystallography-to-3d-print/ 
 
 
*Highlights (for review)
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